for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Wockhardt Limited

WCKH.NS

Latest Trade

263.75INR

Change

-1.60(-0.60%)

Volume

590,975

Today's Range

260.05

 - 

269.50

52 Week Range

146.70

 - 

411.65

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
265.35
Open
265.00
Volume
590,975
3M AVG Volume
14.73
Today's High
269.50
Today's Low
260.05
52 Week High
411.65
52 Week Low
146.70
Shares Out (MIL)
110.74
Market Cap (MIL)
29,206.36
Forward P/E
--
Dividend (Yield %)
--

Next Event

Wockhardt Ltd Annual Shareholders Meeting

Latest Developments

More

Dr.Reddy's Completes Acquisition Of Some Business Divisions Of Wockhardt

India's Wockhardt Reports Profit In March Quarter

Wockhardt Gets US FDA Qualified Infectious Disease Product Designation For WCK 6777

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Wockhardt Limited

Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.

Industry

Biotechnology & Drugs

Contact Info

Wockhardt Towers

Bandra Kurla Complex, Bandra (East)

400051

India

+91.22.26534444

http://www.wockhardt.com/

Executive Leadership

Habil F. Khorakiwala

Executive Chairman of the Board

Manas Datta

Chief Financial Officer

Murtaza H. Khorakiwala

Managing Director, Executive Director

Huzaifa H. Khorakiwala

Executive Director

Narendra Singh

Company Secretary

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
1.07
Price To Book (MRQ)
1.09
Price To Cash Flow (TTM)
49.15
Total Debt To Equity (MRQ)
94.09
LT Debt To Equity (MRQ)
57.92
Return on Investment (TTM)
-3.68
Return on Equity (TTM)
-2.06

Latest News

Latest News

BRIEF-India's Wockhardt Reports Profit In March Quarter

* MARCH QUARTER CONSOL NET PROFIT 482.9 MILLION RUPEES VERSUS LOSS OF 144.7 MILLION RUPEES YEAR AGO Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Approves Raising Up To 15 Bln Rupees Via Equity

* APPROVES RAISING FUNDS UP TO 15 BILLION RUPEES VIA EQUITY Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Ltd -To Consider Fund Raising

* WOCKHARDT LTD -TO CONSIDER FUND RAISING Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Gets US FDA Qualified Infectious Disease Product Designation For WCK 6777

* RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777 Source text: https://bit.ly/3eCjXZ5 Further company coverage:

BRIEF-Wockhardt Seeks Members' Nod For Sale Of Unit To Dr. Reddy's Laboratories

* SEEKS MEMBERS' NOD FOR SALE OF UNIT TO DR. REDDY'S LABORATORIES Source text for Eikon: Further company coverage:

BRIEF-India's Wockhardt Ltd March Qtr Consol Loss Narrows

* MARCH QUARTER CONSOL NET LOSS 1.55 BILLION RUPEES VERSUS LOSS OF 1.75 BILLION RUPEES LAST YEAR

BRIEF-Wockhardt Says To Consider Raising Of Funds Through Issuance Of NCDs

* SAYS TO CONSIDER RAISING OF FUNDS THROUGH ISSUANCE OF NON-CONVERTIBLE DEBENTURES Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Gets Shareholders' Nod To Give Loans/Guarantees/Securities Or Invest Up to 60 Bln Rupees

* GETS SHAREHOLDERS' NOD TO GIVE LOANS/GUARANTEES/SECURITIES OR MAKE INVESTMENT(S) UPTO 60 BILLION RUPEES Source text: http://bit.ly/2qnDYey Further company coverage:

BRIEF-India's Wockhardt Gets Shareholders' Nod To Give Loans Or Guarantee Among Others

* GETS SHAREHOLDERS' NOD TO GIVE LOANS OR GUARANTEE AMONG OTHERS WORTH UP TO 60 BILLION RUPEES Source text - http://bit.ly/2IvLonq Further company coverage:

BRIEF-Wockhardt Seeks Shareholders' Nod For Investments Worth Up To 60 Bln Rupees

* SEEKS SHAREHOLDERS' NOD TO GIVE LOANS OR PROVIDE SECURITIES AMONG OTHERS WORTH UP TO 60 BILLION RUPEES Source text - http://bit.ly/2H7ZLh7 Further company coverage:

BRIEF-India's Wockhardt Dec Qtr Consol Loss Narrows

* DEC QUARTER CONSOL NET LOSS 407.6 MILLION RUPEES VERSUS LOSS OF 539.1 MILLION RUPEES LAST YEAR

BRIEF-India's Wockhardt posts Sept-qtr consol loss

* Sept quarter consol net loss 33.3 million rupees versus profit of 170.2 million rupees last year

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up